Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Reuters NewMedia - December 19, 2006
Several recent medical studies have reported circumcision cuts the risk of HIV infection among men by 50-60 percent, and the findings have been backed by UNAIDS.
"These (African) countries should now prepare how to introduce circumcision on a large scale," UNAIDS chief Dr. Peter Piot told Reuters. "The science is clear."
Baby boys should be targeted first but then attention should switch to adolescent boys and adult men, said Piot, who is in New Delhi to meet Indian officials on how they plan to tackle the world's largest HIV/AIDS caseload.
In 2005, UNAIDS said that more research was needed into the possible benefits of circumcision before it could be promoted as part of national HIV programs.
One U.S.-Ugandan study found male circumcision also reduces infections in female partners by 30 percent.
Muslim and Jewish men have to be circumcised according to religious beliefs, and Piot said that UNAIDS understood advocating mass circumcision was a religiously and culturally sensitive issue for many people.
"Changing that is touching very much on the core of values. That is going to make it more complicated than any other medical issue that I can think of."
But he said given the grim HIV situation in southern Africa, it was important to promote the idea of widespread circumcision.
"We are faced with an absolute crisis where you have 20-40 percent of adults being HIV-positive ... you need to use every scientifically proven method to bring down the new infections."
South Africa, Botswana and Nambia are among the worst hit countries in the region, while Swaziland has an infection rate of around 50 percent, UNAIDS says.
Piot said that even if large-scale circumcision was introduced, countries should continue to promote condom use as well as abstinence.
061219
RE061239
Copyright © 2006 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .